Interleukin-1 gene cluster and IL-1 receptor polymorphisms in Iranian patients with systemic lupus erythematosus

Z Tahmasebi, M Akbarian, S Mirkazemi… - Rheumatology …, 2013 - Springer
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease of unknown etiology
with a complex pathogenesis involving multiple genetic and environmental contributions …

STAT4 confers risk for rheumatoid arthritis and systemic lupus erythematosus in Mexican patients

OB Ramírez, JFM Rincón, REB Cobos, IA Ávila… - Immunology …, 2016 - Elsevier
STAT4 has been consistently associated with several autoimmune diseases, including
rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). The aim of this study was …

Systemic lupus erythematosus immune complexes increase the expression of SLAM family members CD319 (CRACC) and CD229 (LY-9) on plasmacytoid dendritic …

N Hagberg, J Theorell, H Schlums… - The Journal of …, 2013 - journals.aai.org
Patients with systemic lupus erythematosus (SLE) display an activated type I IFN system due
to unceasing IFN-α release from plasmacytoid dendritic cells (pDCs) stimulated by nucleic …

[HTML][HTML] Immune-regulatory mechanisms in systemic autoimmune and rheumatic diseases

Y Takakubo, YT Konttinen - Journal of Immunology Research, 2012 - hindawi.com
Systemic autoimmune and rheumatic diseases (SAIRDs) are thought to develop due to the
failure of autoimmune regulation and tolerance. Current therapies, such as biologics, have …

Cryptotanshinone ameliorates the pathogenesis of systemic lupus erythematosus by blocking T cell proliferation

Y Du, L Du, Z He, J Zhou, C Wen, Y Zhang - International …, 2019 - Elsevier
Systemic lupus erythematosus (SLE) is a chronic, devastating autoimmune disorder
associated with severe organ damage. Recently, the role of Signal Transducer and Activator …

Cytokines in systemic lupus erythematosus: their role in pathogenesis of disease and possible therapeutic opportunities

L Tahernia, S Namazi, N Rezaei, V Ziaee - Rheumatology Research, 2017 - rheumres.org
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that may involve
several organs. The disease is characterized by a recurring pattern of remission and flare …

[PDF][PDF] Nigella sativa L. as immunomodulator and preventive effect on renal tissue damage of lupus mice induced by pristane

Z Hikmah, A Endaryanto, IDG Ugrasena, AS Rahaju… - Heliyon, 2022 - cell.com
Introduction Nigella sativa L. is an herbal plant with Thimoquinone as the main therapeutic
properties. This plants has been shown to cure for various diseases and affected the …

[PDF][PDF] TNF-α messenger ribonucleic acid (mRNA) in patients with nonalcoholic steatohepatitis

N Alaaeddine, J Sidaoui, G Hilal, R Serhal… - European cytokine …, 2012 - researchgate.net
Background and aim: tumor necrosis factor (TNF)-plays a significant role in the
pathogenesis of nonalcoholic steatohepatitis (NASH). A few studies have confirmed high …

[HTML][HTML] PPP2R2B hypermethylation causes acquired apoptosis deficiency in systemic autoimmune diseases

IK Madera-Salcedo, BE Sánchez-Hernández… - JCI insight, 2019 - ncbi.nlm.nih.gov
Chronic inflammation causes target organ damage in patients with systemic autoimmune
diseases. The factors that allow this protracted response are poorly understood. We …

The importance of assessing medication exposure to the definition of refractory disease in systemic lupus erythematosus

L Arnaud, N Zahr, N Costedoat-Chalumeau… - Autoimmunity …, 2011 - Elsevier
Treatment of patients with Systemic Lupus Erythematosus (SLE) who have active disease
refractory to current therapeutic strategies continues to be a real challenge. Here, we …